Cubist Systematic Strategies, LLC Verrica Pharmaceuticals Inc. Transaction History
Cubist Systematic Strategies, LLC
- $20.3 Billion
- Q2 2025
A detailed history of Cubist Systematic Strategies, LLC transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 1,957 shares of VRCA stock, worth $15,558. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,957Holding current value
$15,558% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding VRCA
# of Institutions
50Shares Held
16.3MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY8.88MShares$70.6 Million1.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$17.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.13MShares$8.98 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny907KShares$7.21 Million0.0% of portfolio
-
Sovran Advisors, LLC San Diego, CA750KShares$5.97 Million0.07% of portfolio
About Verrica Pharmaceuticals Inc.
- Ticker VRCA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,094,100
- Market Cap $327M
- Description
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...